Kumar Budur

Kumar Budur, MD, MS, is the Chief Medical Officer at Harmony Biosciences. He leads Harmony Biosciences' growing pipeline and oversees functional areas of Development, Clinical Operations, Biostatistics and Portfolio Management.

Prior to Harmony Biosciences, Dr. Budur spent approximately 6 years each at AbbVie and Takeda, where he held positions of increasing responsibilities. A nationally recognized expert in Research and Development, he has overseen programs ranging from late discovery, early clinical development to late clinical development, and post-marketing studies. He has experience in progressing small molecules, biologics, drug-device combination through various stages of Development. Dr. Budur was involved with four New Drug Applications (NDAs) and was the lead for the registration clinical trials, submission, and approval process of two NDAs.

Dr. Budur was trained at Cambridge University in the UK, and Cleveland Clinic and completed his Residency in Psychiatry and Fellowships in Neurophysiology and Sleep Medicine. He is Board Certified in Psychiatry and Sleep Medicine and holds a master's degree in clinical research from Case Western Reserve University. Dr. Budur has published over 45 original research papers in peer reviewed journals, edited four books, and chaired National and International seminars and symposiums.